Literature DB >> 20044003

Apoptosis of peripheral blood lymphocytes in Parkinson patients.

Màtil Calopa1, Jordi Bas, Antonio Callén, Mariona Mestre.   

Abstract

Neuronal cell death by apoptosis is a mechanism involved in Parkinson's disease and indirect signs of apoptosis have been found in brain neurons and blood lymphocytes. The present study was aimed to directly assess the presence of enhanced apoptosis in lymphocytes from 89 idiopathic Parkinson's disease patients, 33 untreated and 56 treated, compared with 33 healthy individuals. The study of both spontaneous and activation-induced apoptosis of T-lymphocyte subsets by annexin-V binding and flow cytometry showed that Parkinson patients increased the expression of Fas in circulating CD4(+) T cells, mainly "naive," that correlated with the decrease of these cells in blood. Spontaneous and activation-induced apoptosis of CD4(+) T-cell subsets were also significantly increased. Thus, in Parkinson patients, peripheral blood CD4(+) T cells have an increased susceptibility to apoptosis with Fas involvement. This fact explains the decrease in the number of CD4(+) T-cell subsets observed in Parkinson and could be related to the neurodegenerative process. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044003     DOI: 10.1016/j.nbd.2009.12.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  32 in total

1.  Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

Authors:  Natasa Kustrimovic; Emanuela Rasini; Massimiliano Legnaro; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-29       Impact factor: 4.147

2.  LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Authors:  Yulia Y Tyurina; Daniel E Winnica; Valentina I Kapralova; Alexandr A Kapralov; Vladimir A Tyurin; Valerian E Kagan
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

Review 3.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

4.  Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?

Authors:  Marie-Francoise Doursout; Michael S Schurdell; Lauren M Young; Uzondu Osuagwu; Diana M Hook; Brian J Poindexter; Mya C Schiess; Diane L M Bick; Roger J Bick
Journal:  J Interferon Cytokine Res       Date:  2013-04-19       Impact factor: 2.607

5.  Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function.

Authors:  Gavin I Ellis; Lianteng Zhi; Ravi Akundi; Hansruedi Büeler; Francesc Marti
Journal:  Eur J Immunol       Date:  2013-09-14       Impact factor: 5.532

Review 6.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

7.  Evidence for Peripheral Immune Activation in Parkinson's Disease.

Authors:  Xueping Chen; Weihua Feng; Ruwei Ou; Jiao Liu; Jing Yang; Jiajia Fu; Bei Cao; Yongping Chen; Qianqian Wei; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2021-04-30       Impact factor: 5.750

8.  CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.

Authors:  Jessica A Hutter Saunders; Katherine A Estes; Lisa M Kosloski; Heather E Allen; Kathryn M Dempsey; Diego R Torres-Russotto; Jane L Meza; Pamela M Santamaria; John M Bertoni; Daniel L Murman; Hesham H Ali; David G Standaert; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-11       Impact factor: 4.147

9.  Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

Authors:  Isabelle St-Amour; Mélanie Bousquet; Isabelle Paré; Janelle Drouin-Ouellet; Francesca Cicchetti; Renée Bazin; Frédéric Calon
Journal:  J Neuroinflammation       Date:  2012-10-09       Impact factor: 8.322

Review 10.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Authors:  Vanesa Sanchez-Guajardo; Christopher J Barnum; Malú G Tansey; Marina Romero-Ramos
Journal:  ASN Neuro       Date:  2013-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.